ロード中...
Is oxygen a key factor in the lipodystrophy phenotype?
BACKGROUND: The lipodystrophic syndrome (LD) is a disorder resulting from selective damage of adipose tissue by antiretroviral drugs included in therapy controlling human-immunodeficiency-virus-1. In the therapy cocktail the nucleoside reverse transcriptase inhibitors (NRTI) contribute to the develo...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1624831/ https://ncbi.nlm.nih.gov/pubmed/17049073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-5-27 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|